SCHEMBL25543239

SCHEMBL25543239

N#Cc1ccc(N(c2ccc(-c3nc4ccccc4o3)cc2)c2ccc(-c3cccc4c3oc3ccccc34)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.41
TP53 P04637 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
ALOX5 P09917 1/20 0.40
CHRNB4 P30926 1/20 0.39
CHRNA3 P32297 1/20 0.39
CHRNA7 P36544 1/20 0.39
CHRNA10 Q9GZZ6 1/20 0.39
CHRNA9 Q9UGM1 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544169 0.99 NPC1 (0.40) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25543324 0.93 NPC1 (0.41) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25544765 0.93 CHRNB4 (0.36) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25544453 0.92 NPC1 (0.40) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL23328455 0.92 NPC1 (0.48) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25543155 0.89 NPC1 (0.46) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25543489 0.88 ALOX5 (0.39) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL25543628 0.88 NPC1 (0.45) NPC1TP53KDM4EALDH1A1HPGD
SCHEMBL23328760 0.88 ALOX5 (0.49) ALOX5TNKSPRKDCABCG2
SCHEMBL25543175 0.88 ALOX5 (0.49) ALOX5TNKSPRKDCABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 NPC1 2875/4885TP53 2490/4885KDM4E 142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.